Hi ,

We have some exciting news about two fantastic speakers who will be joining us at the conference!

Wolfram & Quake Live in San Jose: The AI + Bio Tour!

The Global Synthetic Biology Conference is right around the corner, and Stephen Wolfram and Stephen Quake are the latest to join the main stage for a captivating exchange. You won't want to miss this thoughtful discussion between two intellectual giants!

This highly anticipated session will bridge computational theory, biophysics, and AI, highlighting the intersection where complex algorithms meet biological data.  You can expect a fusion of perspectives, highlighting how interdisciplinary collaboration can drive innovation and solve some of the most challenging problems in science today.

Register by Friday, February 9th, and save $200 on your conference pass using promo code AIxBIO-200.


SynBioBeta’s Annual Synthetic Biology Investment Report  Insights Into What Could Be In Store for ‘24

Our annual synthetic biology investment report will be coming out soon. I will be joined by Mark Bunger, CTO & Cofounder·Futurity Systems, in a live webinar on Wednesday, February 21, 2024, to discuss the financial health of the synthetic biology field. Register now to be a part of this vital conversation! Mark and I will answer your questions at the end of our presentation, and we will provide a link where you can download the final version of the 2024 Synthetic Biology Financial Report.

Here’s a shout-out to some of our new 2024 SynBioBeta Conference sponsors:

  • Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals.

  • Mayfield is an early-stage venture capital firm with a people-first philosophy and $3 billion under management. The Firm has a proven track record of partnering with founders starting at the inception stage to help build iconic companies that leverage innovations in IT and biology.

  • bitBiome, Inc. has created bit-GEM, the world's largest microbial genome database, and is developing bit-QED, an enzyme discovery and engineering platform that contributes to multiple industries, including biomanufacturing.

  • Baruch Future Ventures (BFV) is a venture capital and family office fund that works with innovators and entrepreneurs to address pain points in climate-sensitive and resource-limited markets.

  • Antheia is the next-generation pharmaceutical ingredient producer transforming essential medicine supply chains to end drug shortages.

Innovation Endeavors has closed a $630M for Fund V to invest in the intersection of science and technology. Eric Schmidt, the former Google CEO, started the firm in 2010 with Dror Berman, Scott Brady, and Rick Scanlon. The venture capital firm will invest in visionaries working on climate, intelligent software, engineering health, and supply chain.

John Cumbers, George Church and Eric Schmidt (Founder of Innovation Endeavors) speaking at SynBioBeta 2019.

  • Protein design meets biosecurity: In an editorial for Science, David Baker and George Church discuss how the power and accuracy of computational protein design have been increasing with the incorporation of artificial intelligence (AI) approaches.

Insights (Exclusive Content):

Industry News:

  • LanzaJet Unveils World's First Ethanol to Sustainable Aviation Fuel (SAF) Facility: LanzaJet, a leading sustainable fuels technology company, inaugurated the LanzaJet Freedom Pines Fuels facility in collaboration with government officials, industry leaders, partners, and supporters. As an aside, Kit McDonnell, Director of Communications at LanzaTech, is the Chair of the ClimateTech & Environment Track at the 2024 SynBioBeta Conference. She is helping drive essential conversations at the intersection of SynBio and environmental issues. 

Charles Dimmler, CEO of Checkerspot, speaking at SynBioBeta 2023.

Other news:

Who's hiring?

Email Marketing by ActiveCampaign